Related references
Note: Only part of the references are listed.Pharmacodynamics-Mediated Drug Disposition (PDMDD) and Precursor Pool Lifespan Model for Single Dose of Romiplostim in Healthy Subjects
Yow-Ming C. Wang et al.
AAPS JOURNAL (2010)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database
Mellissa Yong et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
James B. Bussel et al.
BLOOD (2009)
Vascular complications after splenectomy for hematologic disorders
Shelley E. Crary et al.
BLOOD (2009)
Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases
Bethan Psaila et al.
BLOOD (2009)
Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production
Diane Nugent et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
One Year Follow-Up of Children and Adolescents With Chronic Immune Thrombocytopenic Purpura (ITP) Treated With Rituximab
Brigitta U. Mueller et al.
PEDIATRIC BLOOD & CANCER (2009)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:: a double-blind randomised controlled trial
David J. Kuter et al.
LANCET (2008)
A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children
Jason Glanz et al.
PEDIATRICS (2008)
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The epidemiology of immune thrombocytopenic purpura
Patrick F. Fogarty et al.
CURRENT OPINION IN HEMATOLOGY (2007)
Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: The kids' ITP tools
Robert J. Klaassen et al.
JOURNAL OF PEDIATRICS (2007)
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Recent advances in the treatment of childhood immune thrombocytopenic purpura
Michael Tarantino
SEMINARS IN HEMATOLOGY (2006)
The pathogenesis of immune thrombocytopaenic purpura
N Cooper et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura
CM Bennett et al.
BLOOD (2006)
Childhood ITP:: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS)
P Imbach et al.
PEDIATRIC BLOOD & CANCER (2006)
Splenectomy and chronic thromboembolic pulmonary hypertension
X Jaïs et al.
THORAX (2005)
How I treat idiopathic thrombocytopenic purpura (ITP)
DB Cines et al.
BLOOD (2005)
Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rho(D) immune globulin intravenous administration for immune thrombocytopenic purpura
AR Gaines
BLOOD (2005)
AMG531 stimulates megakaryopoiesis in vitro by binding to Mp1
VC Broudy et al.
CYTOKINE (2004)
Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand
B Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies
LM Aledort et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group
T Kuhne et al.
JOURNAL OF PEDIATRICS (2003)
Grading of hemorrhage in children with idiopathic thrombocytopenic purpura
GR Buchanan et al.
JOURNAL OF PEDIATRICS (2002)
Vascular dementia in patients with immune thrombocytopenic purpura
YS Ahn et al.
THROMBOSIS RESEARCH (2002)
Thrombocytopenia caused by the development of antibodies to thrombopoietin
JZ Li et al.
BLOOD (2001)
Share Paper
